Introducing a new investigative true crime series: "Radioactive: The Karen Silkwood Mystery." Karen Silkwood’s death 50 years ago this November continues to haunt Oklahoma and the nation. The 28-year-old plutonium plant worker died in a fatal crash while driving to meet a reporter with The New York Times allegedly to deliver evidence documenting unsafe conditions at the plant. Two reporters who covered the Silkwood story in 1974 have spent years trying to piece together what many in Oklahoma speculate: Karen Silkwood may have died for what she knew. Fifty years later, hear newly-discovered investigative tapes, deathbed conversations and long-awaited interviews reexamining what happened that night. Listen to Ep. 1 on Apple Podcasts,  Spotify,  Amazon Music, or  wherever you get your podcasts.

Trailer: 'Radioactive: The Karen Silkwood Mystery'

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.

Is it a network?

We wanted to tell you about another podcast you might like: "Pop Culture Moms," new from our friends at ABC Audio and "Good Morning America." In "Pop Culture Moms," best friends Andie and Sabrina talk the joys and challenges of parenting, and the lessons they've learned from watching some of the most iconic moms in TV and movies. Search for "Pop Culture Moms" on your favorite podcast platform or click here to jump to it ---&gt; https://link.chtbl.com/popculturemomss1?sid=thedropout Learn more about your ad choices. Visit megaphone.fm/adchoices

Introducing 'Pop Culture Moms' from ABC & Good Morning America

In a special bonus episode of "The Dropout: Elizabeth Holmes on Trial," we break down what happened during Holmes' sentencing hearing and what is next for the once-lauded Theranos founder. Learn more about your ad choices. Visit megaphone.fm/adchoices

Bonus: Sentenced

Amanda Seyfried, the lead actress of Hulu’s “The Dropout” and the show’s creator and showrunner Liz Meriwether join host Rebecca Jarvis for a wide-ranging conversation about the making of the Hulu limited series based on the ABC News podcast. Seyfried has been nominated for an Emmy in the category of Outstanding Lead Actress in a Limited or Anthology Series or Movie for her portrayal of Elizabeth Holmes, one of six nominations for the Hulu series this year.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Bonus: Amanda and The Other Liz

Rebecca Jarvis sits down with Brad Mielke, host of ABC News’ “Start Here” podcast to talk about the conviction of former Theranos president Ramesh “Sunny” Balwani. Follow “Start Here” on Apple Podcasts (https://apple.co/2maaMIF), Spotify (https://spoti.fi/3nNbcBC), or wherever you listen to get the day’s top headlines every morning. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Sunny Balwani Verdict

The new Hulu limited series based on this podcast and starring Oscar-nominee Amanda Seyfried as Elizabeth Holmes is out now. And in case you missed 20/20’s behind-the-scenes look at the show, we wanted to drop it in this feed, so you can listen now. You’ll hear from the stars of the Hulu series and a member of the jury that convicted Elizabeth. And be sure to follow the 20/20 podcast on Apple Podcasts, Spotify, or wherever you're listening now for more true crime stories from ABC News. Learn more about your ad choices. Visit megaphone.fm/adchoices

'20/20': The Rise and Con of Elizabeth Holmes

Three years after Elizabeth Holmes was charged with 11 counts of fraud, the verdict we’ve all been waiting for is finally in. After seven days and over 50 hours of deliberation, the 12 members of the jury -- one of whom gave us details that you’ll hear for the first time on this podcast -- found Holmes guilty on four counts. They were hung on an additional three. How did they reach these conclusions? And what happens next? What will affect Elizabeth’s sentencing, and how will the appeal process work in this case? Finally, what will the ripple effects be for Silicon Valley?  Learn more about your ad choices. Visit megaphone.fm/adchoices

The Verdict

More than three months, 32 witnesses and three juror dismissals after the criminal trial of Elizabeth Holmes began, attorneys for the prosecution and defense had the chance to make their final appeals with closing arguments. Who presented the most compelling case? What resonated most with the eight men and four women of the jury? Whatever the case, the fate of Elizabeth Holmes could be days away from being decided. Learn more about your ad choices. Visit megaphone.fm/adchoices

Closing Arguments

The testimony of Elizabeth Holmes continues this week, finally concluding after seven days. And in a surprising move, the defense calls no further witnesses, resting its case. So after three months and dozens of witnesses, who came out on top? Will the defense strategy pay off? Soon, both sides will have one last shot to make a case in closing arguments before 12 jurors decide the fate of Elizabeth Holmes.  Learn more about your ad choices. Visit megaphone.fm/adchoices

The Defense Rests

This week, the most jaw-dropping testimony in this trial yet. Elizabeth Holmes fights back tears telling the court she was raped when she was at Stanford and claims she was in an emotional and physically abusive relationship with her former boyfriend and Theranos COO Sunny Balwani, who firmly denies all allegations. Plus, the government begins its cross-examination, and while Elizabeth Holmes seemed to be able to recall her life in vivid detail throughout the defense’s questioning, her memories suddenly got more hazy, even non-existent, at times. Will the jury be thrown by the sudden evasiveness? And ultimately, will charges of abuse negate the allegations of fraud?   Learn more about your ad choices. Visit megaphone.fm/adchoices

Accusations and Evasions

This week, Elizabeth Holmes returns to the stand, presenting herself as a confident CEO with a noble mission who also naively took experts at their word. She meticulously details how she built her business -- even admitting to having doctored those pharmaceutical documents -- but implies over and over again that she relied on information given to her by scientists, doctors and board members to solidify her understanding of where her company stood. Will it be enough to convince a jury that she had no intent to defraud investors? Learn more about your ad choices. Visit megaphone.fm/adchoices

Reframing the Narrative

In a monumental week in the trial of United States v. Elizabeth A. Holmes, the prosecution introduced its final week of witnesses before resting its case. Among them, a patient who received troubling results from a Theranos HIV test and a journalist whose damaging interviews with Elizabeth were played for the first time in court. And in a literal final-hour shocker, the defense called Elizabeth Holmes to the stand. Did the government bring its case home? Did Elizabeth begin to sway the jury? Learn more about your ad choices. Visit megaphone.fm/adchoices

The Prosecution Rests & Elizabeth Speaks

In this episode, we hear from two Theranos lab directors -- one who never met Elizabeth or stepped foot into the company’s lab, another who ultimately voided more than 50,000 Theranos tests after a damning government inspection. And we hear from an irate investor who says Elizabeth Holmes cut off communication with him when he asked for basic information about the company. Plus, 10 weeks into the trial, with only 24 witnesses out of a possible 181 on the government’s initial list having taken the stand, we hear a surprising update from prosecutor Jeffrey Schenk: This week might be the prosecution’s last before it rests its case.   Learn more about your ad choices. Visit megaphone.fm/adchoices

The Beginning of the End

Nine weeks into the criminal trial of Elizabeth Holmes, we’ve heard from dozens of witnesses -- Elizabeth’s colleagues, board members, investors, clients, scientists, accountants and corporate executives. It's impossible not to feel the repetition. We learn that a fake Pfizer memo wasn’t the only document Theranos falsified, and we’re introduced to a man with deep connections to many of the central players in Elizabeth’s orbit. Patterns in the prosecution’s questioning are beginning to become clear, and experts show us it’s all part of a greater plan.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Patterns

This week, we hear from high-profile companies and individuals who invested millions of dollars into Theranos, the prosecution reiterating that these investments were made on the basis of what they say was a pattern of misinformation, exaggeration and outright lies coming from Elizabeth Holmes herself. And we hear from a Pfizer scientist who speaks to the supposedly doctored Pfizer document that Theranos showed investors to help lure them in.   Learn more about your ad choices. Visit megaphone.fm/adchoices

The Investors

This week, we got a peek into how things at Theranos could at times be a full-on family affair. Elizabeth recruited her brother Christian to the company. He, in turn, recruited five of his Delta Tau Delta fraternity brothers to join him. The group would come to be known as “The Therabros.” We hear from one Therabro who would rise to the rank of Elizabeth’s lead of strategic operations. He interacted with VIP investors, board members, military officials and business partners, and revealed to the court what the government says was a disturbing pattern of misinformation.  Learn more about your ad choices. Visit megaphone.fm/adchoices

The Therabros

Theranos’ biggest clients, Walgreens and Safeway, are on the stand this week, testifying to what exactly they say they were told before signing multimillion-dollar deals with the blood testing startup. In email exchanges, text messages and board presentations, the prosecution paints a picture of deception while the defense claims the industry giants should’ve known better. Plus, we hear from Sunny Balwani’s dermatologist of 15 years, who happened to also become Theranos’ lab director. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Clients

This week, two jurors ask to be excused, citing stress around punishment and the responsibilities in deciding the future of Elizabeth Holmes. A young woman, with unusual ties to this case, gives her perspective as a trial observer, and a veteran Silicon Valley investor puts the Theranos saga in larger context.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Crime and Punishment

This week, we hear some shocking insights from a former Theranos lab director who says he tried to stop the train before it ran off the tracks. From failing machines to a lack of proficiency testing, he tells of the pressure he felt to vouch for tests while maintaining his integrity as a lab director. And he describes how he says he tried to delay the Walgreens launch, pleading with a “nervous” Elizabeth, who went forward nonetheless. But does an aggressive and lengthy cross-examination undermine his claims? Learn more about your ad choices. Visit megaphone.fm/adchoices

Sounding the Alarm

This week, a high-profile witness from Elizabeth’s superstar board of directors surprises the courtroom by taking the stand: 4-star general and former U.S. Secretary of Defense James Mattis. He speaks of being dazzled by the potential of Theranos’ devices on the battlefield and the disillusionment he felt when the full story came to light. Plus, we meet a patient whose Theranos test results led to a terrifying ordeal.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Get Started

Download the App